Sectors

KVUE
Kenvue Inc.
18.80
21200 x 18.78
9600 x 18.80
bid
ask
+
0.39
2.12%
15400 @ 04:36 PM
18.75 -0.05 (0.27%)
Ytd 8.99%
1y -11.28%
18.47
day range
18.88
14.02
52 week range
22.87
Open 18.46 Prev Close 18.41 Low 18.47 High 18.88 Mkt Cap 36.10B
Vol 43.27M Avg Vol 19.41M EPS 0.84 P/E 22.38 Forward P/E 14.87
Beta 0.50 Short Ratio 3.39 Inst. Own 95.45% Dividend 0.83 Div Yield 4.65
Ex Div Date 05-13 Earning 08-06 50-d Avg 17.53 200-d Avg 17.25 1yr Est 19.50
Earning
Date For Estimate Reported Surprise surprise %
2026-05-07 2026-03 0.27 0.32 0.05 18.52%
2026-02-17 2025-12 0.22 N/A N/A N/A
2026-02-17 2025-12 0.22 0.27 0.05 22.73%
2025-11-03 2025-09 0.27 N/A N/A N/A
2025-11-03 2025-09 0.27 0.28 0.01 3.70%
2025-08-07 2025-06 0.28 0.29 0.01 3.57%
Upgrade / Downgrade
Date Firm Action From To
2026-04-15 Citigroup Upgrade Neutral Neutral
2026-04-14 Barclays Upgrade Equal-Weight Equal-Weight
2026-04-07 UBS Upgrade Neutral Neutral
2026-03-06 Barclays Upgrade Equal-Weight Equal-Weight
2026-02-18 Canaccord Genuity Upgrade Hold Hold
2026-02-18 Citigroup Upgrade Neutral Neutral
Profile
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Insider Holder
Date Name Relation Quantity Description
2026-03-09 ALVARADO LUANI Chief Operating Officer 61.42K Conversion of Exercise of derivative security
2026-03-09 LAWSON CARLTON Officer 111.42K Conversion of Exercise of derivative security
2025-03-04 MEURER JAN Officer 33.18K Conversion of Exercise of derivative security
2025-03-04 MONGON THIBAUT Chief Executive Officer 216.47K Conversion of Exercise of derivative security
2025-12-14 PERRY KIRK L Chief Executive Officer 62.55K Conversion of Exercise of derivative security
2025-03-04 RUH PAUL Chief Financial Officer 56.20K Conversion of Exercise of derivative security
Institution Ownership
Report Date Organization Position Value Percentage
2026-03-30 Blackrock Inc. 145.30M 2.73B 7.57%
2026-03-30 FMR, LLC 135.09M 2.54B 7.04%
2026-03-30 Vanguard Capital Management LLC 124.42M 2.34B 6.48%
2026-03-30 State Street Corporation 119.57M 2.24B 6.23%
2026-03-30 Vanguard Portfolio Management LLC 92.46M 1.74B 4.82%
2026-03-30 Pentwater Capital Management Lp 52.00M 976.30M 2.71%
Fund Ownership
Report Date Organization Position Value Percentage
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 60.84M 1.14B 3.17%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 48.69M 914.15M 2.54%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 41.39M 777.17M 2.16%
2026-04-29 iShares Trust-iShares Core S&P 500 ETF 24.78M 465.30M 1.29%
2026-04-29 Fidelity Concord Street Trust-Fidelity 500 Index Fund 24.55M 460.99M 1.28%
2026-05-30 SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust 23.16M 434.80M 1.21%
Dividend
Dividend Date
0.2075 2026-05-13
0.2075 2026-02-11
0.2075 2025-11-12
0.2075 2025-08-13
0.205 2025-05-14
0.205 2025-02-12